← Leaderboards
Kyong-Mi Chang
Veterans Admin Palo Alto Health Care Sys
$7,695,421
Attributed
$7,695,421
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $767.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,695,421 · 5
VA$0 · 2
By mechanism
R01$5,061,873 · 2
U01$2,612,820 · 1
M01$20,728 · 2
I01$0 · 2
Top collaborators
- Philip S Tsao9 shared
- Rudolph C Johnson1 shared
Most similar at Veterans Admin Palo Alto Health Care Sys
Same institution · by research overlap
- Philip S Tsao$12,695,628
- Minang Pravin Turakhia$0
- Alex Sox-Harris$1,488,939
- Daniel Michael Blonigen$0
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchLiver DiseasesPhenotypeLiver CirrhosisInsightHepatitis CBaseFrequencies (Time Pattern)PublishingImmuneFunctional DisorderT-LymphocyteVirusCirrhosisCellular ImmunityHepatitis C VirusChronicCross-Sectional StudiesRelative (Related Person)ResponseProgramsLiteratureInterleukin-10Human Subject
Grant awards (39)
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2025 · VA · contact PI
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2024 · VA · contact PI
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2023 · VA · contact PI
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2023 · VA · contact PI
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2022 · VA
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2021 · VA
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2020 · VA
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2018 · VA
Genetics of Cardiometabolic Diseases in the VA Population$0
I01 · FY2017 · VA
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B$350,481
U01 · FY2014 · DK · contact PI
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B$497,497
U01 · FY2013 · DK · contact PI
Mechanisms of Cellular Immune Dysfunction in Patients with Hepatitis C Virus and$0
I01 · FY2013 · VA · contact PI
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B$327,157
U01 · FY2012 · DK · contact PI
Mechanisms of Cellular Immune Dysfunction in Patients with Hepatitis C Virus and$0
I01 · FY2012 · VA · contact PI
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B$499,337
U01 · FY2011 · DK · contact PI
Mechanisms of Cellular Immune Dysfunction in Patients with Hepatitis C Virus and$0
I01 · FY2011 · VA · contact PI
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B$452,101
U01 · FY2010 · DK · contact PI
Cellular Immunity and the Outcome of Hepatitis C Virus Infection$315,000
R01 · FY2010 · AI · contact PI
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B$400,000
U01 · FY2009 · DK · contact PI
Cellular Immunity and the Outcome of Hepatitis C Virus Infection$315,000
R01 · FY2009 · AI · contact PI
Mechanisms of Cellular Immune Dysfunction in Patients with Hepatitis C Virus and$0
I01 · FY2009 · VA · contact PI
Cellular immunity - outcome hepatitis C virus infection$304,162
R01 · FY2008 · AI · contact PI
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B$86,247
U01 · FY2008 · DK · contact PI
Cellular immunity - outcome hepatitis C virus infection$309,721
R01 · FY2007 · AI · contact PI
Cellular immunity - outcome hepatitis C virus infection$318,641
R01 · FY2006 · AI · contact PI
Cellular immunity - outcome hepatitis C virus infection$325,980
R01 · FY2005 · AI
CELLULAR IMMUNITY &THE OUTCOME OF HEPATITIS C VIRUS INFECTION$11,931
M01 · FY2005 · RR
ALCOHOL/CELLULAR IMMUNITY IN HCV AND HIV INFECTION$404,782
R01 · FY2004 · AA
Cellular immunity - outcome hepatitis C virus infection$325,660
R01 · FY2004 · AI
Cellular Immunity &the Outcome of Hepatitis C Virus Infection$7,102
M01 · FY2004 · RR
Alcohol and Cellular Immunity in HCV and HIV Infection$1,695
M01 · FY2004 · RR
ALCOHOL/CELLULAR IMMUNITY IN HCV AND HIV INFECTION$392,992
R01 · FY2003 · AA
CELLULAR IMMUNITY OUTCOME HEPATITIS C VIRUS INFECTION$245,535
R01 · FY2003 · AI
ALCOHOL/CELLULAR IMMUNITY IN HCV AND HIV INFECTION$381,546
R01 · FY2002 · AA
CELLULAR IMMUNITY OUTCOME HEPATITIS C VIRUS INFECTION$211,931
R01 · FY2002 · AI
ALCOHOL/CELLULAR IMMUNITY IN HCV AND HIV INFECTION$370,433
R01 · FY2001 · AA
CELLULAR IMMUNITY OUTCOME HEPATITIS C VIRUS INFECTION$231,439
R01 · FY2001 · AI
ALCOHOL/CELLULAR IMMUNITY IN HCV AND HIV INFECTION$384,353
R01 · FY2000 · AA
CELLULAR IMMUNITY OUTCOME HEPATITIS C VIRUS INFECTION$224,698
R01 · FY2000 · AI